Literature DB >> 17957304

Inhibition of SARS coronavirus helicase by bismuth complexes.

Nan Yang1, Julian A Tanner, Zai Wang, Jian-Dong Huang, Bo-Jian Zheng, Nianyong Zhu, Hongzhe Sun.   

Abstract

A series of bismuth complexes were synthesized and characterized, and most of them exhibited inhibition against the SARS coronavirus helicase ATPase and duplex-unwinding activities at micromolar concentrations.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17957304     DOI： 10.1039/b709515e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  22 in total

1.  Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.

Authors:  Adeyemi O Adedeji; Kamalendra Singh; Nicholas E Calcaterra; Marta L DeDiego; Luis Enjuanes; Susan Weiss; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

2.  Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.

Authors:  Dale L Barnard; Yohichi Kumaki
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

3.  Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13.

Authors:  Na-Ra Lee; Hyun-Mi Kwon; Kkothanahreum Park; Sangtaek Oh; Yong-Joo Jeong; Dong-Eun Kim
Journal:  Nucleic Acids Res       Date:  2010-07-29       Impact factor: 16.971

Review 4.  The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.

Authors:  E J Snijder; E Decroly; J Ziebuhr
Journal:  Adv Virus Res       Date:  2016-09-14       Impact factor: 9.937

5.  2-(2-Pyrid-yl)pyridinium (2,2'-bipyridine-κN,N')tetra-kis-(nitrato-κO,O')bis-muthate(III).

Authors:  Zhao-Hui Meng; Shu-Shen Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-20

Review 6.  Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.

Authors:  Young-Sam Keum; Yong-Joo Jeong
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

Review 7.  Discovering new medicines targeting helicases: challenges and recent progress.

Authors:  William R Shadrick; Jean Ndjomou; Rajesh Kolli; Sourav Mukherjee; Alicia M Hanson; David N Frick
Journal:  J Biomol Screen       Date:  2013-03-27

Review 8.  SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets.

Authors:  Lorenzo Subissi; Isabelle Imbert; François Ferron; Axelle Collet; Bruno Coutard; Etienne Decroly; Bruno Canard
Journal:  Antiviral Res       Date:  2013-11-20       Impact factor: 5.970

9.  Polymeric architectures of bismuth citrate based on dimeric building blocks.

Authors:  Nan Yang; Yan An; JiWen Cai; LiHong Hu; YiBo Zeng; ZongWan Mao; GuanHua Chen; HongZhe Sun
Journal:  Sci China Chem       Date:  2010-10-27       Impact factor: 9.445

10.  Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.

Authors:  Douglas C Wolf; Christine H Wolf; David T Rubin
Journal:  Am J Gastroenterol       Date:  2020-08       Impact factor: 12.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.